Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BAX | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | ATP6V0B | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | TTC22 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | DMC1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | MMP9 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | AL137164.1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | SLC27A1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | C5orf38 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | PLRG1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | CBWD1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |